Condition:   Advanced Cancer
Intervention:   Behavioral: Living with Hope Program
Sponsor:   University of Saskatchewan
Recruiting - verified March 2010

Condition:   Patients With Pacemaker With Conduction Problems
Intervention:   Device: Pacing mode
Sponsors:   Montreal Heart Institute;   Sorin Group Canada
Active, not recruiting - verified November 2009

Condition:   Chronic Hepatitis C
Intervention:   Drug: Pegylated Interferons (Peg-IFN) and Ribavirin
Sponsors:   University of Manitoba;   Roche Pharma AG
Recruiting - verified February 2010

Conditions:   HIV Infection;   Herpesvirus 2, Human;   HIV Infections
Interventions:   Drug: valacyclovir;   Drug: Placebo
Sponsor:   University Health Network, Toronto
Recruiting - verified March 2010

Conditions:   Anxiety;   Depression
Interventions:   Behavioral: mindful meditation;   Behavioral: interpersonal therapy
Sponsors:   University of Saskatchewan;   Royal University Hospital Foundation, Saskatoon, SK, Canada
Enrolling by invitation - verified March 2009

Conditions:   Arthritis, Rheumatoid;   Osteoarthritis
Interventions:   Drug: celecoxib;   Drug: Ibuprofen;   Drug: Naproxen
Sponsors:   Pfizer;   The Cleveland Clinic
Recruiting - verified March 2010

Condition:   Breast Cancer
Interventions:   Drug: anastrozole;   Drug: chemotherapy;   Drug: exemestane;   Drug: letrozole;   Drug: tamoxifen citrate
Sponsors:   Eastern Cooperative Oncology Group;   National Cancer Institute (NCI);   Southwest Oncology Group;   Cancer and Leukemia Group B;   American College of Surgeons;   North Central Cancer Treatment Group;   NCIC Clinical Trials Group;   National Surgical Adjuvant Breast and Bowel Project (NSABP)
Recruiting - verified March 2010

Condition:   Prostate Cancer
Interventions:   Procedure: 7800 cGy/39 fractions in 8 weeks;   Procedure: 6000 cGy/20 fractions in 4 weeks
Sponsors:   Ontario Clinical Oncology Group (OCOG);   Canadian Institutes of Health Research (CIHR);   Trans-Tasman Radiation Oncology Group (TROG)
Recruiting - verified February 2010

Condition:   Sarcoma
Interventions:   Biological: PEG-interferon alfa-2b;   Drug: cisplatin;   Drug: doxorubicin hydrochloride;   Drug: etoposide;   Drug: ifosfamide;   Drug: methotrexate
Sponsors:   Children's Oncology Group;   National Cancer Institute (NCI);   University College London Hospitals
Recruiting - verified March 2010

Condition:   Breast Cancer
Interventions:   Drug: exemestane;   Drug: tamoxifen citrate
Sponsors:   International Breast Cancer Study Group;   National Cancer Institute (NCI);   Breast International Group
Recruiting - verified March 2010

Condition:   Lymphoma
Interventions:   Biological: bleomycin sulfate;   Biological: filgrastim;   Biological: pegfilgrastim;   Drug: ABVD regimen;   Drug: BEACOPP regimen;   Drug: cyclophosphamide;   Drug: dacarbazine;   Drug: doxorubicin hydrochloride;   Drug: etoposide;   Drug: prednisone;   Drug: procarbazine hydrochloride;   Drug: vinblastine;   Drug: vincristine sulfate
Sponsors:   European Organization for Research and Treatment of Cancer;   Lymphoma Trials Office;   Groupe d'Etudes de Lymphomes de L'Adulte;   Grup per l'Estudi dels Limfomes de Catalunya i Balears;   NCIC Clinical Trials Group;   Australasian Leukaemia and Lymphoma Group (ALLG);   Nordic Lymphoma Group
Active, not recruiting - verified June 2009

Condition:   Sarcoma
Interventions:   Biological: dactinomycin;   Drug: busulfan;   Drug: doxorubicin hydrochloride;   Drug: etoposide;   Drug: ifosfamide;   Drug: melphalan;   Drug: vincristine sulfate;   Procedure: autologous hematopoietic stem cell transplantation;   Procedure: conventional surgery;   Radiation: radiation therapy
Sponsors:   University Hospitals, Leicester;   National Cancer Institute (NCI);   Children's Cancer and Leukaemia Group;   Societe Francaise Oncologie Pediatrique;   European Organization for Research and Treatment of Cancer;   Gesellschaft fur Padiatrische Onkologie und Hamatologie - Germany;   Gesellschaft fur Padiatrische Onkologie und Hamatologie - Austria;   Swiss Group for Clinical Cancer Research;   EBMT Solid Tumors Working Party;   Children's Oncology Group
Recruiting - verified March 2010

Condition:   Breast Cancer
Interventions:   Procedure: adjuvant therapy;   Radiation: radiation therapy
Sponsors:   NCIC Clinical Trials Group;   National Cancer Institute (NCI);   National Surgical Adjuvant Breast and Bowel Project (NSABP);   Radiation Therapy Oncology Group;   Southwest Oncology Group;   Trans-Tasman Radiation Oncology Group (TROG);   North Central Cancer Treatment Group
Active, not recruiting - verified March 2010

Conditions:   Hypertension, Pulmonary;   Respiratory Insufficiency;   Infant, Newborn, Diseases;   Meconium Aspiration;   Persistent Fetal Circulation Syndrome;   Pneumonia, Aspiration;   Respiratory Distress Syndrome
Interventions:   Drug: Inhaled nitric oxide;   Drug: Placebo
Sponsors:   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD);   Medical Research Council of Canada
Terminated - verified November 2009